fashion -WSS

fashion

author：hotspot 2025-09-07 06:46:34 - browse：4

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Biden administration opens offers in Medicare drug price negotiations

hotspot

WSS

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Report cites 'urgent' need to recruit more diverse clinical trial participants

Tome Biosciences co

Biden administration opens offers in Medicare drug price negotiations

Cybersecurity threat forces Lurie Children's to take systems offline

Cybersecurity threat forces Lurie Children's to take systems offline

Wikipedia

fashion

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Study gives hint on South Asians’ higher risk of cardiovascular disease

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Hollywood unions extend contract negotiations for actors

Congress considering partial increase for doctor pay in Medicare

Walensky prepares to leave CDC — and Congress — behind

The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

Resistance to opioid

Report cites 'urgent' need to recruit more diverse clinical trial participants

Juul documents reveal insider tactics on political lobbying

Apple Vision Pro: A first look at health apps on the new VR headset

Artificial intelligence use in health care faces greater scrutiny in 2024

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

hotspot

hotspot

entertainment

hotspot